UnicoCell Biomed Co., Ltd.(TW:6794)
NT$64.80+0.30 (+0.47%)
TW:6794
UnicoCell Biomed Co., Ltd. financials statements
NT$64.80
At close:+0.30 (+0.47%)
UnicoCell Biomed Co., Ltd. (6794) Financial Statements
UnicoCell Biomed Co., Ltd. Financial Overview
UnicoCell Biomed Co., Ltd.'s market cap is currently NT$4.10B. The company's EPS TTM is NT$-1.89; its P/E ratio is -34.13; UnicoCell Biomed Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 30.10M | NT$ 31.88M | NT$ 24.59M | NT$ 14.40M | NT$ 8.18M |
| Gross Profit | NT$ -221.00K | NT$ 20.57M | NT$ 17.90M | NT$ 8.20M | NT$ 5.83M |
| Operating Income | NT$ -130.28M | NT$ -102.92M | NT$ -96.28M | NT$ -92.11M | NT$ -87.34M |
| EBITDA | NT$ -109.73M | NT$ -64.03M | NT$ -56.28M | NT$ -65.63M | NT$ -59.45M |
| Net Income | NT$ -114.84M | NT$ -93.07M | NT$ -84.11M | NT$ -91.16M | NT$ -86.37M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 752.02M | NT$ 553.52M | NT$ 477.28M | NT$ 213.89M | NT$ 141.02M |
| Total Assets | NT$ 946.01M | NT$ 777.89M | NT$ 685.93M | NT$ 414.31M | NT$ 297.71M |
| Total Debt | NT$ 62.02M | NT$ 68.24M | NT$ 74.33M | NT$ 66.59M | NT$ 21.58M |
| Net Debt | NT$ 21.02M | NT$ 58.66M | NT$ 54.43M | NT$ 12.95M | NT$ -109.27M |
| Total Liabilities | NT$ 80.58M | NT$ 93.28M | NT$ 89.49M | NT$ 80.46M | NT$ 34.71M |
| Stockholders' Equity | NT$ 865.43M | NT$ 684.61M | NT$ 596.44M | NT$ 333.85M | NT$ 263.00M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -96.81M | NT$ -67.22M | NT$ -81.53M | NT$ -78.21M | NT$ -85.70M |
| Operating Cash Flow | NT$ -91.31M | NT$ -61.52M | NT$ -65.55M | NT$ -63.60M | NT$ -61.71M |
| Investing Cash Flow | NT$ -173.49M | NT$ -122.35M | NT$ -307.20M | NT$ -164.99M | NT$ -23.80M |
| Financing Cash Flow | NT$ 296.07M | NT$ 173.54M | NT$ 339.01M | NT$ 151.38M | NT$ -5.66M |
Currency in TWD
